Enter your Email Address


Useful Links

Know What The Insiders Are Doing!
Stock Trading Software

More Links




[Most Recent Quotes from www.kitco.com]

[Most Recent Quotes from www.kitco.com]




Champions Biotechnology Inc. (CSBR.OB) Obtains Exclusive License for Cancer Treatment in Collaboration with Yale and Southern Research Institute

QualityStocks (November 18th, 2009) Writes:

Champions Biotechnology Inc. focuses on oncology drug developments and preclinical platforms and data to enhance and accelerate the value of those drugs. The company today announced an exclusive licensing agreement with Yale University and Southern Research Institute for the development of Bithionol for cancer treatment.

According to scientists from Yale and Southern Research, Bithionol, which is available for parasitic infections, shows activity against solid cancerous tumors and may be effective in treating melanoma, prostate, breast, lung and other cancers.

Per the agreement, Yale and Southern Research will receive an upfront payment, as well as milestone payments and royalties; Champions has exclusive rights for continued development of Bithionol for all oncology applications, and will use its predictive Biomerk Tumorgraft platform to determine optimal applications and efficient clinical development. If Champions is able to deliver results, the company will conduct human clinical trials.

“We are excited to work with Champions’ experienced scientific

...
More »

Posted in Investing Lessons, Small & Micro Cap | No Comments »

GenVec’s TNFerade Nears NDA Status (NASDAQ:GNVC)

Michael Vlaicu (September 9th, 2009) Writes:

GenVec, Inc.

(Public, NASDAQ:GNVC)

StocksHaven Investments profiles a clinical stage biopharmaceutical company developing gene-based therapeutic drugs and vaccines. Its lead product candidate, TNFerade biologic (TNFerade), is being developed for use in the treatment of cancer, and is currently undergoing Phase III trials which are expected to be completed by Q1 2010. In addition to its therapeutic product development programs, GenVec is working with collaborators to develop new applications for its technology through its vaccine development programs. The Company is developing a vaccine in animal health against foot-and-mouth disease and preventative vaccines for malaria, human immunodeficiency virus (HIV), respiratory syncytial virus, and Herpes Simplex Virus Type 2 (HSV-2). Surrounded by cash infusions through grants, mutual and institutional investors, multi-purpose products with billion dollar market potential, and an already flowing revenue stream – GenVec is one company you shouldn’t pass by.

About

Genvec

...
More »
Tags for this Post:
adenovector delivery, adenovector delivery technology, adenovector technology, adenovector vaccine candidate, adenovirus, Agricultural Research Service, Allergy, America, Analyst, and Lead Investment Analyst, antibodies, Antigenics Inc., Apple Inc, Associate Professor, balance disorders, bank of america corp, Barclays, Biotechnology, California, cancer, Cancer Research, Cancers, care for patients with balance disorders, ceo, Chemotherapy, clinical disease, Dendreon Corporation;, director, Douglas J. Swirsky, esophageal cancer, Executive Vice President, Executive Vice President of Research and Development, Fda, fibrosis;, Food Supply, foot-and-mouth disease, founder, Gaithersburg;, gene expression, gene therapy, GenVec Inc., Head And Neck Cancer, hearing loss;, HIV, Infectious Diseases, Laszlo Zsak, lead therapeutic product candidate, locally advanced pancreatic cancer, Major, Malaria, manager, Marvin Grubman, Maryland, meat products, Michael Vlaicu;, multi-purpose products, National Institute of Allergy, National Institute of Allergy and Infectious Diseases of the National Institutes of Health, Naval Medical Research Center, necrosis, Oncologix Inc., Pancreatic Cancer, parasitic disease, Patrick Swazy, Paul H. Fischer, Pfizer Inc, Ph.D., Pharmaceutical, Plum Island Animal Disease Center, president and chief executive officer, Professor of Human Oncology, Q1, radiation, rectal cancer, Researchers of the Livestock Sciences, Reuters, Royce Micro, SAIC-Frederick Inc., San Francisco, second-generation vaccine candidate, Spartan Micro, stage biopharmaceutical;, Steve Jobs, Stocks to Watch, targeted radiation therapy, therapy for locally advanced pancreatic cancer, TherAtoh, TNFerade;, TNFerade™;, transcriptional start site, treatment of inoperable, treatment of locally advanced pancreatic cancer;, treatment of pancreatic cancer, treatment of various cancers;, tumor, tumors, U.S. Department of Agriculture, U.S. Food and Drug Administration, United Kingdom, United States, University of California at San Francisco, University of California Irvine Comprehensive Digestive Disease Center, University of Denver, University Of Wisconsin, USD, USDA, vaccine candidate, Vaccine Research Center, Vaccine Research Center/National Institute, Vaccines, Vice President and Chief Financial Officer, Vice President of Research and Development, Wisconsin, Yahoo, yale, Yale University School of Medicine

Posted in Stocks to Watch | No Comments »

PennyOmega.com Stocks Upgraded, Downgraded and Short Highlights Before the Bell Friday September 4, 2009

Penny Omega (September 4th, 2009) Writes:

 

PennyOmega.com Hot Stock News & Alerts!

________________________________________

FREE Daily Stock Alerts From PennyOmega.com

signup3m

________________________________________

 

Friday September 4, 2009

PennyOmega.com Stock Report!

**************************************************************

Callidus Software Inc. (NASDAQ: CALD), the leader in Sales Performance Management (SPM), today announced that Medical Mutual of Ohio has selected Callidus Software’s Insurance Suite and Business Process Management Suite (BPM) to manage its sales performance, incentive compensation programs and broker onboarding processes. Under the agreement, signed in the third quarter

...
More »
Tags for this Post:
Associate Professor, Callidus Software Inc.;, Cancers, Chief Financial Officer, China, China Technology Development Group Corporation, Company’s Nominating Committee, Delcath Systems Inc., Expert Group Inc., Florida, Fort Lauderdale, Frederick Tang, Gary Leung, Insurance Suite, International Liver Cancer Association, Italy, James F. Pingpank, leader in Sales Performance, manager, Medical Mutual of Ohio, medical technology, Medicines Company, melanomas, metastases, Milan, New Drug;, PennyOmega.com, PHP, Professor of Surgery, software applications, Solar Energy Products, stock featured on our site;, Stocks to Watch, Teva Parenteral Medicines Inc., TrueInformation®, U.S. Food and Drug Administration, United States, University of Pittsburgh School of Medicine, USD, Vice President

Posted in Stocks to Watch | No Comments »

PennyOmega.com Stock Report! 8/20/09, APNT, MLKNA, PBIB, ICE, WFC, SPNG

Penny Omega (August 20th, 2009) Writes:

PennyOmega.com Stock Report!

PennyOmega.com Hot Stock News & Alerts!

signup3m

 

Thursday August 20, 2009

PennyOmega.com Stock Report!

**************************************************************

Applied Nanotech Holdings, Inc. (OTCBB: APNT) announced that it has been selected by the U.S. Department of Energy to receive a contract of approximately $750,000 for the development of non-contact, printable metallic inks for silicon solar cells.

MedLink International, Inc. (OTCBB: MLKNA) is pleased to announce the appointment of Abha Agrawal, MD, FACP to the company’s Medical Advisory Board. Dr. Agrawal is the Interim Medical Director of Kings County Hospital Center, Brooklyn, NY. Prior to this role, she was the Chief Medical Information Officer of the Central Brooklyn Family Health Network (CBFHN) and the Associate Medical Director of Kings County

...
More »
Tags for this Post:
Agrawal, Applied Nanotech Holdings Inc., Associate Medical Director, Associate Professor, Associate Professor of Medicine as well as Medical Informatics, Brooklyn, Chief Medical Information Officer, energy futures, energy futures contracts, Green Bridge Industries, guard, Interim Medical Director, Kings County Hospital, Kings County Hospital Center, Leading Points Corporation, London, Market Commentary, MedLink International Inc., military agencies, military e-commerce sites, New York, new york stock exchange, Oil, oil market regulation, PBI Bank, PennyOmega.com, Porter Bancorp Inc;, Professor of Medicine, SpongeTech Delivery Systems Inc, SpongeTechs, stock featured on our site;, Stocks to Watch, SUNY Downstate Medical Center, U.K. Financial Services Authority, U.S. Commodity Futures Trading Commission, U.S. Department of Energy, United States, USD, Wells Fargo & Company

Posted in Market Commentary, Stocks to Watch | No Comments »


Newsletter

No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.